ザルトリウス・ステディム・ジャパン Official site

In this webinar, we will introduce Sartorius's innovative virus quantification device, Virus Counter Plus. Virus Counter Plus employs flow cytometry technology that allows for the direct measurement of virus particle counts in just a few hours, compared to traditional plaque assays and qPCR, enabling rapid virus quantification. The only work required for measurement is mixing the sample with the reagent, eliminating the need for skilled techniques. This prevents the task from becoming dependent on specific individuals and significantly reduces training burdens. Additionally, it is equipped with an auto-sampler, achieving high-throughput measurements. By setting up dozens of samples before leaving work, automatic analysis can proceed overnight, allowing results to be checked the following morning. This accelerates development speed, enables real-time monitoring of processes, and facilitates quick decision-making during manufacturing. 【Seminar Overview】 ▪ Date: October 16 (Thursday) from 3 PM (approximately 30 minutes) ▪ Method: Webinar recorded broadcast [Japanese, free of charge] *We apologize, but participation from companies in the same industry and email addresses other than those from your organization is not permitted. Thank you for your understanding.

We will be exhibiting and presenting a luncheon seminar at BioJapan 2025, which will be held at Pacifico Yokohama from October 8 to 10, 2025. At our booth, we will introduce our cell line development services and media optimization services that achieve a scalable fed-batch process with a monoclonal antibody titer of up to 10 g/L in just 9 weeks, from DNA to RCB. We will also showcase single-use culture vessels for process development. In addition, during the luncheon seminar, we will provide a clear overview of Sartorius' CLD services, making it easy to understand for those who are new to the topic. If you are considering shortening timelines, optimizing product quality, or exploring flexible development strategies, please join us. We look forward to seeing you there. Event Overview: October 8 (Wed) - 10 (Fri), 2025, Pacifico Yokohama Exhibition Booth: Small Booth Number D-109 Luncheon Seminar: Title: Minimizing Risks in CHO Cell Line Development through Automation and Predictive Models Seminar Date and Time: October 9 (Thu) 11:30 AM - 12:30 PM

We will be exhibiting and presenting a seminar at TIDES Asia 2025, which will be held in Kyoto from February 26 to 28, 2025. TIDES Asia is the leading conference in Asia that gathers experts in oligonucleotides, peptides, mRNA, and genome editing therapeutics. At this conference, we plan to showcase high-throughput TFF equipment for parallel screening and hold a seminar on innovative solutions for peptide therapeutic manufacturing. We look forward to your visit. 【Event Overview】 Date: February 26 (Wednesday) - 27 (Friday), 2025 Location: The Westin Miyako Hotel Kyoto *Pre-registration required 【Our Seminar】 Title: Fit for Future: Advancing Bioprocess Manufacturing by Identifying Top Performing Clones and Enhancing Productivity through Process Intensification Seminar Date and Time: 27th (Thursday) at 15:45

To maximize the performance of CHO cells, it is necessary to select the optimal medium for each clone and further optimize the process parameters. Sartorius offers a variety of basic media and feeds suitable for Fed-batch culture of major CHO cell lines such as CHO-DG44, K1, S, and GS. In this webinar, we will introduce a case study that combines these CHO media, the automated microbioreactor Ambr15, and the experimental design software MODDE to conduct medium screening and process optimization in a short period. We will also provide information about our Benchmark Study service, which allows you to outsource the selection of the optimal medium and process development for your specific cell line to our research institute in Germany. 【Seminar Overview】 ▪ Date: March 6, 2025 (Thursday) from 3:00 PM (approximately 40 minutes) ▪ Method: Webinar recorded broadcast [Japanese, Free] If you are unable to participate on the day, please register first. We will send you a viewing URL later. *We kindly ask that participants from other companies in the same industry, as well as those using email addresses not affiliated with your organization, refrain from joining. Thank you for your understanding.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Sartorius has developed CHO cell lines for over 300 projects, with 7 projects approved and more than 80 in clinical trials. The projects include IgG1, 2, 4, multi-specific antibodies, Fc fusion proteins, enzymes, hormones, new drugs, and biosimilars. Our customers range from large companies to startups, with over 70% of them being repeat clients. In this webinar, we will introduce the details of our flexible and comprehensive services, including CHO cell line development, MCB/WCB manufacturing and testing, molecular characterization, FUT8 Knock Out, provision of optimized media, and process enhancement. *We sincerely apologize, but we kindly ask that participants refrain from joining with email addresses other than those from your company or organization. Thank you for your understanding.